Related Experiment Video
Updated: Dec 27, 2025

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
Published on: March 18, 2014
Antitumor Effect of miR-1294/Pyruvate Kinase M2 Signaling Cascade in Osteosarcoma Cells
Quan Yuan1, Honghao Yu1, Jianhua Chen1
1Department of Orthopedic Surgery, Shengjing Hospital of China Medical University, Shenyang 110004, People's Republic of China.
Background:
MicroRNAs (miRNAs) can act as negative regulators of gene expression, and play a crucial role in cancer progression. The aim of this study was to investigate the role of miR-1294/pyruvate kinase M2 (PKM2) axis in osteosarcoma cells in vitro and in vivo.
Methods:
The function of miR-1294 and its association with PKM2 in osteosarcoma cells were studied by real-time PCR, CCK-8, Western blot, scratch test, transwell assay, flow cytometry, and dual-luciferase reporter assays. The effect of miR-1294 on tumor growth in vivo was evaluated in a subcutaneous xenograft model of osteosarcoma.
Results:
miR-1294 was downregulated in osteosarcoma cells. Forced overexpression of miR-1294 inhibited cell proliferation, migration, and invasion, and induced G0/G1 arrest and apoptosis. Consistently, protein expression levels of proliferating cell nuclear antigen, c-Myc, cyclin D1, active matrix metalloproteinase 2, and active matrix metalloproteinase 9 were decreased, and cleaved caspase 3 and cleaved PARP were increased following miR-1294 overexpression. Moreover, we demonstrated that PKM2 was a target of miR-1294 in osteosarcoma cells, and the effects caused by miR-1294 mimic were reversed by the overexpression of PKM2. Furthermore, we found that upregulation of miR-1294 inhibited tumorigenesis of osteosarcoma cells in vivo, which was accompanied by downregulation of PKM2.
Conclusion:
Our results revealed that miR-1294/PKM2 signaling cascade exerts important roles in the regulation of tumor progression, implying that this pathway may serve as a potential therapeutic target in osteosarcoma.
Insights
MicroRNA-1294 (miR-1294) is downregulated in osteosarcoma. Upregulating miR-1294 inhibits tumor growth by targeting pyruvate kinase M2 (PKM2), suggesting a potential therapeutic strategy.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- MicroRNAs (miRNAs) are key regulators of gene expression implicated in cancer progression.
- Osteosarcoma is a primary bone malignancy with significant metastatic potential.
Purpose of the Study:
- To investigate the role of the miR-1294/pyruvate kinase M2 (PKM2) axis in osteosarcoma.
- To evaluate miR-1294's function in osteosarcoma cell proliferation, migration, invasion, apoptosis, and tumorigenesis in vitro and in vivo.
Main Methods:
- Real-time PCR, CCK-8 assays, Western blot, scratch tests, transwell assays, and flow cytometry were used to assess miR-1294 function in osteosarcoma cells.
- Dual-luciferase reporter assays confirmed PKM2 as a direct target of miR-1294.
- Subcutaneous xenograft models were employed to evaluate the in vivo effect of miR-1294 on tumor growth.
Main Results:
- miR-1294 was found to be downregulated in osteosarcoma tissues and cells.
- Overexpression of miR-1294 significantly inhibited osteosarcoma cell proliferation, migration, and invasion, while inducing apoptosis and cell cycle arrest.
- PKM2 was identified as a direct target of miR-1294, and its overexpression reversed the inhibitory effects of miR-1294. In vivo studies showed that miR-1294 upregulation suppressed osteosarcoma tumorigenesis.
Conclusions:
- The miR-1294/PKM2 signaling pathway plays a critical role in regulating osteosarcoma progression.
- This pathway represents a promising therapeutic target for osteosarcoma treatment.
More Related Videos
04:25Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation